Chester County News and Community Website
WILMINGTON, DE — The LYCRA Company recently launched LYCRA ANTISTATIC fiber globally for use in workwear and personal protective equipment to address static discharge risks in industrial environments.
LYCRA Company Launches Antistatic Fiber for Workwear, PPE Read More
WILMINGTON, DE — AstraZeneca reported that its experimental drug tozorakimab reduced moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease in a Phase III trial.
AstraZeneca Drug Reduces COPD Exacerbations in Phase III Trial Read More
WILMINGTON, DE — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) recently received a Discipline Review Letter from the U.S. Food and Drug Administration identifying only minor administrative changes for its ketamine application …
NRx Reports FDA Feedback, Progress on Ketamine Application Read More
WILMINGTON, DE — Charlton Aria Acquisition Corporation (Nasdaq: CHARU) recently received a notice from Nasdaq stating it is not in compliance with listing requirements due to its failure to file …
Charlton Aria Receives Nasdaq Notice Over Late 10-K Filing Read More
WILMINGTON, DE — Uplynk recently reported positive financial performance in its first fiscal year as a standalone company, including a double-digit adjusted EBITDA margin and positive cash flow, and projected …
Uplynk Reports Growth, Expands AI and Streaming Services Strategy Read More WILMINGTON, DE — Wrtn Technologies has launched OOC, an AI-driven character chat and interactive storytelling platform, in North America across iOS, Android, and web platforms as part of its expansion …
Wrtn Technologies Launches OOC AI Storytelling Platform in North America Read More WILMINGTON, DE — NRx Pharmaceuticals (Nasdaq: NRXP) said it supports an executive order signed April 18, 2026, directing federal agencies to accelerate research and regulatory pathways for treatments targeting serious …
NRx Pharmaceuticals Responds to Executive Order on Mental Health Treatments Read More
WILMINGTON, DE — The U.S. Food and Drug Administration recently approved RAPIBLYK® (landiolol) for pediatric patients from birth to under 18 years old with supraventricular tachycardia, expanding its use beyond …
FDA Approves Rapiblyk for Pediatric SVT Patients in U.S. Read More
WILMINGTON, DE — Qnity Electronics, Inc. (NYSE: Q) has declared a quarterly dividend of $0.08 per share, payable June 15, 2026, to stockholders of record as of May 29, 2026.
Qnity Electronics Declares Quarterly Dividend of $0.08 Per Share Read More
WILMINGTON, DE — Phreesia has been named to Becker’s Hospital Review’s 2026 list of “Revenue Cycle Management Companies to Know,” recognizing firms involved in managing patient intake, billing, and reimbursement …
Phreesia Named to Becker’s 2026 Revenue Cycle Companies List Read More